{
    "symbol": "CSII",
    "quarter": 3,
    "year": 2022,
    "date": "2022-05-08 07:42:34",
    "content": " So I think what we're really seeing in the coronary segment of our business and the competitive dynamic there is that physicians in these cath labs as they have completed the trialing of the device are really beginning to return to the use of orbital atherectomy for the cases that they encounter, where they're challenged with a high degree of intimal calcium, where there's heavy stenosis, where there's nodular lesions if they're performing imaging, some of these diffuse and long lesions and also where they're encountering multi-vessel disease."
}